11 Best Cancer Stocks to Invest In Now

8. Guardant Health, Inc. (NASDAQ:GH)

Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc. (NASDAQ:GH) completed the acquisition of the health technology company MetaSight Diagnostics. The $149 million acquisition comes as the company gears up for revenue growth in 2026.

With the acquisition, Guardant Health is to gain access to a range of next-generation liquid biopsies designed for the early detection of chronic and acute diseases, including cancer. Guardant is handing over $59 million in advance payments and has pledged up to $90 million in potential regulatory and commercial milestone payments.

MetaSight has carved a niche in developing next-generation diagnostics platforms using computational biology and advanced data analysis to identify disease signals in blood samples. Its acquisition will help strengthen Guardant Health’s research pipeline and expand its precision medicine capabilities.

The acquisition comes when Guardant Health is experiencing robust revenue growth with total revenue soaring 33% year over year in 2025 to $982 million. The increase was driven by growth in the oncology division, where revenue was up 26% to $683.6 million. For 2026, the company projects revenue growth of 27% to 30%, to a range of $1.25 billion to $1.28 billion.

Guardant Health, Inc. (NASDAQ:GH) is a precision oncology company that develops liquid biopsy-based tests to detect cancer early, monitor recurrence, and guide personalized treatment selection. It provides comprehensive, non-invasive genomic profiling for patients with advanced or early-stage cancer.